Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

70 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy

NCT01675882

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • University of California, Rady Childrens Hospital San Diego, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Completed

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

NCT03627767

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • University of Alabama at Birmingham, Dermatology at the Whitaker Clinic Birmingham, Alabama, United States
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • Tien Q Nguyen MD Inc dba First OC Dermatology Fountain Valley, California, United States
View all 235 locations
View Trial Details
Completed

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

NCT00258635

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +1 more
Locations
  • Michigan Respiratory Health and Research Institute Novi, Michigan, United States
  • Clinical Research Institute Minneapolis, Minnesota, United States
  • Regional Allergy & Asthma Consultants Asheville, North Carolina, United States
  • Lovelace Scientific Resources Austin, Texas, United States
View Trial Details
Completed

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • The University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Marvel Research, LLC Huntington Beach, California, United States
  • Alliance Research Centers Laguna Hills, California, United States
View all 216 locations
View Trial Details

Related conditions